Microsporidia are spore-forming, obligate intracellular eukaryotic parasites that infect a wide range of animals , including various aquatic economic animals such as penaeid shrimp, portunid crabs, and fish like Epinephelus and Salmo. Infection frequently leads to severe diseases and significant economic losses. Currently , available therapeutic drugs are limited and often associated with side effects. This study utilized cell-based screening platforms, efficient in vivo screening models, and in vitro sporicidal assay systems to find novel microsporidian inhibitors for the prevention and control of microsporidiosis .
From nearly 8,000 compounds, natural products, and their synthetic analogs, we identified 91 inhibitors that effectively suppressed microsporidian invasion or proliferation in animals or cell lines. Among these inhibitors , benzenesulfonamide derivatives inhibited host cell invasion by inactivating spores; albendazole analogs and fumagillol analogs inhibited intracellular proliferation of microsporidia; while flavone analogs and bisindole derivatives acted by preventing spore germination and reducing spore viability, respectively. Using an Ecytonucleospora hepatopenaei (EHP)-Litopenaeus vannamei infection model and an in vitro efficacy evaluation system, we validated several inhibitors exhibited either in vitro sporicidal activity or in vivo suppression of EHP proliferation. This study identifies various lead compounds with distinct mechanisms of action, encompassing spore inactivation, germination inhibition, and proliferation blockade, providing important candidate molecules for the development of anti-microsporidia therapeutics in aquaculture.